Literature DB >> 19850886

Similarities between forms of sheep scrapie and Creutzfeldt-Jakob disease are encoded by distinct prion types.

Wiebke M Wemheuer1, Sylvie L Benestad, Arne Wrede, Ulf Schulze-Sturm, Wilhelm E Wemheuer, Uwe Hahmann, Joanna Gawinecka, Ekkehard Schütz, Inga Zerr, Bertram Brenig, Bjørn Bratberg, Olivier Andréoletti, Walter J Schulz-Schaeffer.   

Abstract

Transmissible spongiform encephalopathies such as scrapie in sheep, Creutzfeldt-Jakob disease (CJD) in humans, and bovine sporadic encephalopathy in cattle are characterized by the accumulation of a misfolded protein: the pathological prion protein. Ever since bovine sporadic encephalopathy was discovered as the likely cause of the new variant of CJD in humans, parallels between human and animal transmissible spongiform encephalopathies must be viewed under the aspect of a disease risk for humans. In our study we have compared prion characteristics of different forms of sheep scrapie with those of different phenotypes of sporadic CJD. The disease characteristics of sporadic CJD depend considerably on the prion type 1 or 2. Our results show that there are obvious parallels between sporadic CJD type 1 and the so-called atypical/Nor98 scrapie. These parelleles apply to the deposition form of pathological prion protein in the brain, detected by the paraffin-embedded-tissue blot and the prion aggregate stability with regard to denaturation by the chaotropic salt guanidine hydrochloride. The same applies to sporadic CJD type 2 and classical scrapie. The observed parallels between types of sporadic CJD and types of sheep scrapie demonstrate that distinct groups of prion disease exist in different species. This should be taken into consideration when discussing interspecies transmission.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19850886      PMCID: PMC2789619          DOI: 10.2353/ajpath.2009.090623

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Pathogenesis of natural scrapie in sheep.

Authors:  L J van Keulen; B E Schreuder; M E Vromans; J P Langeveld; M A Smits
Journal:  Arch Virol Suppl       Date:  2000

2.  Effects of agent strain and host genotype on PrP accumulation in the brain of sheep naturally and experimentally affected with scrapie.

Authors:  L González; S Martin; I Begara-McGorum; N Hunter; F Houston; M Simmons; M Jeffrey
Journal:  J Comp Pathol       Date:  2002-01       Impact factor: 1.311

3.  A sensitive filter retention assay for the detection of PrP(Sc) and the screening of anti-prion compounds.

Authors:  K F Winklhofer; F U Hartl; J Tatzelt
Journal:  FEBS Lett       Date:  2001-08-10       Impact factor: 4.124

4.  Strain-specified relative conformational stability of the scrapie prion protein.

Authors:  D Peretz; M R Scott; D Groth; R A Williamson; D R Burton; F E Cohen; S B Prusiner
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

5.  Detection of classical and atypical/Nor98 scrapie by the paraffin-embedded tissue blot method.

Authors:  W M Wemheuer; S L Benestad; A Wrede; W E Wemheuer; B Brenig; B Bratberg; W J Schulz-Schaeffer
Journal:  Vet Rec       Date:  2009-05-30       Impact factor: 2.695

6.  Strain characterization of natural sheep scrapie and comparison with BSE.

Authors:  Moira E Bruce; Aileen Boyle; Simon Cousens; Irene McConnell; James Foster; Wilfred Goldmann; Hugh Fraser
Journal:  J Gen Virol       Date:  2002-03       Impact factor: 3.891

7.  The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases.

Authors:  W J Schulz-Schaeffer; S Tschöke; N Kranefuss; W Dröse; D Hause-Reitner; A Giese; M H Groschup; H A Kretzschmar
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

8.  Molecular genetics of human prion diseases in Germany.

Authors:  O Windl; A Giese; W Schulz-Schaeffer; I Zerr; K Skworc; S Arendt; C Oberdieck; M Bodemer; S Poser; H A Kretzschmar
Journal:  Hum Genet       Date:  1999-09       Impact factor: 4.132

9.  Detection of PrP(Sc) in subclinical BSE with the paraffin-embedded tissue (PET) blot.

Authors:  W J Schulz-Schaeffer; R Fatzer; M Vandevelde; H A Kretzschmar
Journal:  Arch Virol Suppl       Date:  2000

Review 10.  Bovine spongiform encephalopathy, chronic wasting disease, scrapie, and the threat to humans from prion disease epizootics.

Authors:  Patrick J Bosque
Journal:  Curr Neurol Neurosci Rep       Date:  2002-11       Impact factor: 5.081

View more
  20 in total

1.  Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.

Authors:  Piero Parchi; Maura Cescatti; Silvio Notari; Walter J Schulz-Schaeffer; Sabina Capellari; Armin Giese; Wen-Quan Zou; Hans Kretzschmar; Bernardino Ghetti; Paul Brown
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

2.  Prion protein glycans reduce intracerebral fibril formation and spongiosis in prion disease.

Authors:  Alejandro M Sevillano; Patricia Aguilar-Calvo; Timothy D Kurt; Jessica A Lawrence; Katrin Soldau; Thu H Nam; Taylor Schumann; Donald P Pizzo; Sofie Nyström; Biswa Choudhury; Hermann Altmeppen; Jeffrey D Esko; Markus Glatzel; K Peter R Nilsson; Christina J Sigurdson
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

Review 3.  Hereditary Human Prion Diseases: an Update.

Authors:  Matthias Schmitz; Kathrin Dittmar; Franc Llorens; Ellen Gelpi; Isidre Ferrer; Walter J Schulz-Schaeffer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

4.  Spongiform encephalopathy in siblings with no evidence of protease-resistant prion protein or a mutation in the prion protein gene.

Authors:  Daniela Varges; Walter J Schulz-Schaeffer; Wiebke M Wemheuer; Insa Damman; Matthias Schmitz; Maria Cramm; Kai Kallenberg; Katayoon Shirneshan; Manar Elkenani; Susanne Markwort; Michael Faist; Jürgen Kohlhase; Otto Windl; Inga Zerr
Journal:  J Neurol       Date:  2013-04-02       Impact factor: 4.849

5.  Distinct stability states of disease-associated human prion protein identified by conformation-dependent immunoassay.

Authors:  Young Pyo Choi; Alexander H Peden; Albrecht Gröner; James W Ironside; Mark W Head
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

6.  Detergents modify proteinase K resistance of PrP Sc in different transmissible spongiform encephalopathies (TSEs).

Authors:  Johanna Breyer; Wiebke M Wemheuer; Arne Wrede; Catherine Graham; Sylvie L Benestad; Bertram Brenig; Jürgen A Richt; Walter J Schulz-Schaeffer
Journal:  Vet Microbiol       Date:  2011-12-14       Impact factor: 3.293

Review 7.  The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.

Authors:  Walter J Schulz-Schaeffer
Journal:  Acta Neuropathol       Date:  2010-06-20       Impact factor: 17.088

8.  Burial of the polymorphic residue 129 in amyloid fibrils of prion stop mutants.

Authors:  Lukasz Skora; Luis Fonseca-Ornelas; Romina V Hofele; Dietmar Riedel; Karin Giller; Jens Watzlawik; Walter J Schulz-Schaeffer; Henning Urlaub; Stefan Becker; Markus Zweckstetter
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

9.  Small ruminant nor98 prions share biochemical features with human gerstmann-sträussler-scheinker disease and variably protease-sensitive prionopathy.

Authors:  Laura Pirisinu; Romolo Nonno; Elena Esposito; Sylvie L Benestad; Pierluigi Gambetti; Umberto Agrimi; Wen-Quan Zou
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

10.  Relationships between PrPSc stability and incubation time for United States scrapie isolates in a natural host system.

Authors:  Catherine E Vrentas; Justin J Greenlee; Trudy L Tatum; Eric M Nicholson
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.